Investing in Innovation: A Conversation with Sam Libby, President and Managing Director at TCB Capital Advisors

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/72/f6/3a/72f63a4f-b9be-e852-5b7d-b4b3d6b1d4f5/mza_17673394441249925433.jpg/600x600bb.jpg

The Current: Discovering Chemistry's Zeitgeist

Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC

323 episodes

1 day ago

To shape the future, you have to understand the current. This is The Current: Discovering Chemistry's Zeitgeist, the student-led show that plugs you directly into the momentum of modern science. We explore how research, leadership, and innovation are fueled by the spirit of our age. Join us for insights from influential minds like Dr. Robert Langer, Chancellor Gary May, Dean Raheem Beyah from Georgia Tech, Dr. Todd Golub from The Broad Institute of Harvard and MIT, and Greg Zuckerman of The Wall Street Journal, in conversations designed to inspire the next generation of scientific leaders.

Chemistry

Science

RSS

All content for The Current: Discovering Chemistry's Zeitgeist is the property of Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Chemistry

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/7605281/7605281-1759924187849-0b130445c78e3.jpg

Investing in Innovation: A Conversation with Sam Libby, President and Managing Director at TCB Capital Advisors

The Current: Discovering Chemistry's Zeitgeist

29 minutes 50 seconds

2 months ago

Investing in Innovation: A Conversation with Sam Libby, President and Managing Director at TCB Capital Advisors

🎙️ Episode Description

In this episode, we sit down with Sam Libby,President and Managing Director at TCB Capital Advisors, whose career has been dedicated to transforming healthcare through strategic investments andpartnerships. With more than 30 completed transactions —spanning mergers and acquisitions, capital raises, and innovative deal structures—Sam has become a trusted advisor at the intersection of finance, science, and patient care. Our conversation dives deep into his origin story—from Rutgers to leading one of the most dynamic advisory firms in healthcare—and explores how his investment philosophy balances patient-centered missions withthe financial discipline demanded by markets. Sam shares case studies from groundbreaking ventures like Clairity, the first FDA-cleared AI breast cancer risk platform, and Altoida, a pioneer in early cognitive assessment technology, offering valuable lessons for founders and investors alike.

We also discuss the critical role of strategicpartnerships, the evolving dynamics between founders and investors, and the exciting frontiers shaping the future of healthcare—from oncology and neurodegeneration to women’s health and digital innovation. Sam highlights how AI and data are reshaping deal-making, due diligence, and commercialization pathways.

Finally, Sam offers practical advice for aspiringthought leaders and entrepreneurs on refining their pitch, stepping into leadership beyond the lab, and positioning themselves for long-term impact in a rapidly evolving industry. Whether you’re a scientist, entrepreneur, investor, or future healthcare leader, this episode provides insightful perspectives on the business of innovation, the art of deal-making, and the mission to improvepatient outcomes.